Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study.

Crane PK, Trittschuh E, Mukherjee S, Saykin AJ, Sanders RE, Larson EB, McCurry SM, McCormick W, Bowen JD, Grabowski T, Moore M, Bauman J, Gross AL, Keene CD, Bird TD, Gibbons LE, Mez J; Executive Prominent Alzheimer's Disease: Genetics and Risk Factors (EPAD:GRF) Investigators.

Alzheimers Dement. 2017 Dec;13(12):1307-1316. doi: 10.1016/j.jalz.2017.04.011. Epub 2017 Jun 15.

2.

Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology.

Monsell SE, Mock C, Fardo DW, Bertelsen S, Cairns NJ, Roe CM, Ellingson SR, Morris JC, Goate AM, Kukull WA.

Alzheimer Dis Assoc Disord. 2017 Jul-Sep;31(3):232-238. doi: 10.1097/WAD.0000000000000179.

3.

Careful neuropsychological testing reveals a novel genetic marker, GSTO1*C, linked to the pre-stage of Alzheimer's disease.

Umlauf E, Rappold E, Schiller B, Fuchs P, Rainer M, Wolf B, Zellner M.

Oncotarget. 2016 Jun 28;7(26):39108-39117. doi: 10.18632/oncotarget.9773.

Supplemental Content

Loading ...
Support Center